PeptidePedia The community reference

Dual incretin agonist: difference between revisions

Diff·revision 16 → 17·04:00, 11 Mar 2025

Difference between revision 16 and revision 17 of Dual incretin agonist. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 16 — 12:33, 15 Feb 2025
BacWaterBarnaby (talk)
add the year of first marketing authorisation, with the regulator named
4,734 bytes +147
Revision 17 — 04:00, 11 Mar 2025
BacWaterBarnaby (talk)
the storage condition applies to the unopened pen; say so
4,734 bytes ±0
No change to the page source.